Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Insulet Corporation - Common Stock
(NQ:
PODD
)
283.51
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Insulet Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Insulet Expands Omnipod® 5 to Four More International Markets
March 18, 2025
From
Insulet Corporation
Via
Business Wire
From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes
March 18, 2025
From
Insulet Corporation
Via
Business Wire
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
↗
March 14, 2025
Via
Benzinga
What's Driving the Market Sentiment Around Insulet?
↗
February 28, 2025
Via
Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
↗
February 24, 2025
Via
Benzinga
Assessing Insulet: Insights From 6 Financial Analysts
↗
February 21, 2025
Via
Benzinga
Insulet to Host Investor Day on June 5, 2025
March 11, 2025
From
Insulet Corporation
Via
Business Wire
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
March 11, 2025
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest...
Via
StockStory
Topics
Artificial Intelligence
Exploring the Growth Potential of INSULET CORP (NASDAQ:PODD) as It Nears a Breakout.
↗
March 03, 2025
Based on fundamental and technical analysis of NASDAQ:PODD we conclude: INSULET CORP (NASDAQ:PODD): a strong growth stock preparing for the next leg up?.
Via
Chartmill
1 Mid-Cap Stock on Our Watchlist and 2 to Ignore
February 28, 2025
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...
Via
StockStory
Earnings Scheduled For February 20, 2025
↗
February 20, 2025
Via
Benzinga
Looking for growth without the hefty price tag? Consider NASDAQ:PODD.
↗
February 14, 2025
Based on Fundamental Analysis it can be said that NASDAQ:PODD is a growth stock which is not overvalued.
Via
Chartmill
$1000 Invested In Insulet 10 Years Ago Would Be Worth This Much Today
↗
February 07, 2025
Via
Benzinga
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)
February 27, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom...
Via
StockStory
Topics
Artificial Intelligence
Which S&P500 stocks are moving on Tuesday?
↗
February 25, 2025
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.
Via
Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
↗
February 25, 2025
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.
Via
Chartmill
These S&P500 stocks are gapping in today's session
↗
February 25, 2025
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends.
Via
Chartmill
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
↗
January 20, 2025
Via
Benzinga
NASDAQ:PODD—A High-Growth Stock Gearing Up for Its Next Upward Move.
↗
January 15, 2025
Is INSULET CORP (NASDAQ:PODD) on the Verge of a Major Breakout as a Strong Growth Stock?
Via
Chartmill
Earnings To Watch: Masimo (MASI) Reports Q4 Results Tomorrow
February 24, 2025
Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings tomorrow after the bell. Here’s what to look for.
Via
StockStory
Integra LifeSciences (IART) Reports Earnings Tomorrow: What To Expect
February 24, 2025
Medical device company Integra LifeSciences (NASDAQ:IART) will be announcing earnings results tomorrow before market hours. Here’s what to look for.
Via
StockStory
Curious about which S&P500 stocks are generating unusual volume on Friday? Find out below.
↗
February 21, 2025
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.
Via
Chartmill
Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst
↗
February 21, 2025
Insulet's Q4 sales grew 17.2% to $597.5 million, exceeding forecasts. Omnipod revenue surged, and 2025 guidance projects up to 20% growth.
Via
Benzinga
These S&P500 stocks are moving in today's pre-market session
↗
February 21, 2025
Curious about the S&P500 stocks that are showing activity before the opening bell on Friday?
Via
Chartmill
Insulet’s (NASDAQ:PODD) Q4: Beats On Revenue, Quarterly Revenue Guidance Slightly Exceeds Expectations
February 20, 2025
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 17.2% year on year to $597.5 million. Guidance for next...
Via
StockStory
Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year
February 20, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Earnings: What To Look For From PODD
February 19, 2025
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be announcing earnings results tomorrow after market close. Here’s what to expect.
Via
StockStory
Why NASDAQ:PODD Is a Standout High-Growth Stock in a Consolidation Phase.
↗
February 06, 2025
Based on a technical and fundamental analysis of NASDAQ:PODD we ask: Why INSULET CORP (NASDAQ:PODD) Is a Promising High-Growth Stock in the Midst of Consolidation.
Via
Chartmill
Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe
January 13, 2025
From
Insulet Corporation
Via
Business Wire
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025
↗
January 13, 2025
Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
